Manipal Health Enterprises IPO

Manipal Health Enterprises IPO is listed on BSE and NSE, priced at ₹560–₹590 per share. The stock debuted at ₹652, delivering a listing gain of 10.5%. The IPO had a lot size of ₹25 shares and a minimum investment of ₹14,750.

Manipal Health Enterprises Limited IPO

Mainboard Listed
₹14,750 (25 Shares)
Minimum Investment
Check Allotment
IPO Dates
Jul 29, 2026 – Jul 31, 2026
Price band
₹560-590 per equity share
Minimum Investment
₹14,750
Issue size
₹9275.21 Cr
Lot size
25
Allotment Date
Aug 3, 2026
Listing
Aug 5, 2026
Listing At
BSE, NSE

IPO timeline

  1. Jul 29, 2026

    Open Date

    Completed

  2. Jul 31, 2026

    Close Date

    Completed

  3. Aug 3, 2026

    Allotment Date

    Completed

  4. Aug 5, 2026

    Listing Date

    Completed

Price Summary

Last closing
715.30 (21.24%)
52 week high
757.70
52 week low
625.45
Last update

Unofficial pre-listing indicator

Manipal Health Enterprises IPO Last Recorded GMP: ₹3

No GMP quote could be verified as recorded before Manipal Health Enterprises IPO listed. A grey-market observation of ₹3 per share was recorded on 5 Aug 2026, 7:15 AM IST, but without a verified listing timestamp it is not treated as the final pre-listing GMP. The shares listed at ₹652. GMP is unofficial and does not forecast or guarantee the actual listing price.

Last recorded GMP
₹3
GMP percentage
1%
Upper price band
₹590
Listing price
₹652

During the recorded period, Manipal Health Enterprises IPO GMP ranged from ₹0 to ₹45.

Manipal Health Enterprises IPO GMP trend (day-wise) 65 observations
Day-wise recorded GMP observations for Manipal Health Enterprises IPO
Date & time GMP Change GMP % Indicative price
₹3 ₹0 1% ₹593
₹3 +₹1 1% ₹593
₹2 ₹0 0% ₹592
₹2 +₹1 0% ₹592
₹1 +₹1 0% ₹591
₹0 ₹0 0% ₹590
₹0 ₹0 0% ₹590
₹0 ₹0 0% ₹590
₹0 ₹0 0% ₹590
₹0 ₹0 0% ₹590

Manipal Health Enterprises IPO Subscription Details

View Subscription Details
Qualified Institutional Buyers (QIBs) 8.54x
Retail Individual Investors (RIIs) 0.97x
Non-Institutional Investors (NIIs) 1.06x
bHNI (>10 Lakhs) 1.13x
sHNI (2-10 Lakhs) 0.94x
Retail 0.97x
Employee 2.32x
Total 5.12x

Manipal Health Enterprises IPO subscription status shows demand across QIB, NII, and retail categories, helping investors understand participation levels.

Last updated:

Manipal Health Enterprises IPO Essentials

Manipal Health Enterprises IPO Details

Manipal Health Enterprises IPO is priced at ₹560-590 per share with a total issue size of 9275.21 crore. The IPO has a lot size of 25 shares and is listed on BSE and NSE.

Issue price
₹560-590 per equity share
Lot size
25 shares
Face value
₹2 Per Equity Share
Issue size
₹9275.21 Cr.
Total issue size
15,72,07,054 shares
(aggregating up to ₹9275.21 crore)
Fresh issue
13,55,93,220 shares
(aggregating up to ₹8000 crore)
Offer for sale (OFS)
2,16,13,834 shares
(aggregating up to ₹1275.21 crore)
Retail Portion
10%
Listing at
BSE, NSE
List price
652.0(NSE)
Listing date
Registrar
Kfin Technologies Limited
Lead manager
Kotak Mahindra Capital Co.Ltd., Axis Capital Ltd., Goldman Sachs (India) Securities Pvt.Ltd., Jefferies India Pvt.Ltd., JP Morgan India Pvt.Ltd., UBS Securities India Pvt.Ltd., DBS Bank India Ltd.

Market Lot Size

Investors can bid for a minimum of 25 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.

Application Lots Shares Amount
Retail (min) 1 25 ₹14,750
Retail(max) 13 325 ₹1,91,750
sHNI(min) 14 350 ₹2,06,500
sHNI(max) 67 1,675 ₹9,88,250
bHNI(min) 68 1,700 ₹10,03,000

Manipal Health Enterprises IPO Documents

Manipal Health Enterprises IPO Reservation

Manipal Health Enterprises IPO reservation details show category-wise allocation of shares. Out of the total 157233715 shares, approximately 29.95% are reserved for QIB, 14.97% for NII, 9.98% for retail investors, 0.18% for employees, and 44.92% for anchor investors.

Investor Category Shares Offered Maximum Allottees
Anchor Investor Shares Offered 70628768 (44.92%)
QIB Shares Offered 47085846 (29.95%)
NII (HNI) Shares Offered 23542922 (14.97%)
bHNI > ₹10L 15695282 (10.01%) 44,844
sHNI < ₹10L 7847640 (5%) 22,422
Retail Shares Offered 15695282 (9.98%) 6,27,811
Employee Shares Offered 280899 (0.18%)
Total Shares Offered 157233715 (100%)

Manipal Health Enterprises IPO Analytics

Manipal Health Enterprises IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.

Manipal Health Enterprises IPO Subscription Status

Manipal Health Enterprises IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.

The IPO is currently subscribed 5.12x, indicating strong demand across investor categories.

As on QIB
NII
bHNI
sHNI
Retail Total
Shares Offered / Reserved 4,70,85,846
2,35,42,922
1,56,95,282
78,47,640
1,56,95,282 8,66,04,949
Day 1 29-07-26 05:00 PM
0.15 x
0.08x
0.08x
0.08x
0.26 x 0.15 x
Day 2 30-07-26 05:00 PM
0.62 x
0.15x
0.14x
0.16x
0.48 x 0.47 x
Day 3 31-07-26 05:00 PM
8.54 x
1.06x
1.13x
0.94x
0.97 x 5.12 x
Total No. of Applications
bHNI sHNI Retail
3,58,620 (Approx) 0.13x 0.79x 0.52x

Manipal Health Enterprises Valuations

Earnings

EPS Pre IPO
₹7.77/-
EPS Post IPO
₹6.97/-
P/E Pre IPO
75.93
P/E Post IPO
84.65

Returns

ROCE
21.88%
RoNW
10.57%
PAT Margin
8.87%

Fundamentals

Price / Book
8.13
Market Cap
₹77,605.68 Cr.

Data sourced from DRHP / RHP • For educational purposes only

Manipal Health Enterprises Financials( In Crs.)

31-Mar-26 31-Mar-25 31-Mar-24
Assets 24,864.50 14,072.08 10,818.83
Revenue 10,520.52 8,362.79 6,265.17
Profit After Tax 916.52 1,081.67 533.20
Net Worth 8,440.92 5,865.66 4,029.22
Reserves & Surplus 8,204.96 5,788.60 3,953.59
Total Borrowing 10,553.43 4,766.83 3,943.98

Manipal Health Enterprises Company & Offer Insights

About Manipal Health Enterprises

Manipal Health Enterprises Limited is a service provider in the field of healthcare and runs a large chain of multi-specialty hospitals, clinics, and diagnostic centers all over the country. It is a constituent of the Manipal Group which was established by T. M. A. Pai.

It provides diversified healthcare facilities that include tertiary and quaternary care, organ transplant, oncology, cardiology, neurology, orthopaedics, and preventive healthcare services. The hospitals maintained by it are well equipped with high-quality medical equipment and have expert medical practitioners working there.

Manipal Health aims at providing quality and patient-oriented care along with the expansion of its presence in the healthcare market through strategic acquisitions, partnerships, and investment in its medical and digital health infrastructure.

As per September 30, 2025, the company had 38 hospitals (48 hospitals on a pro forma basis) with 10,761 licensed beds (12,367 licensed beds on a pro forma basis). They are running 17 clinics as on September 30, 2025.

Manipal Health Enterprises Promoter(s)

Dr.Ranjan Ramdas Pai, Manipal Global Health Services, Memg International Ltd, Kangto Investments Pte.Ltd., Imperius Healthcare Investments Pte.Ltd, Kabru Investments Pte.Ltd. are the company's promoters of Manipal Health Enterprises.

Manipal Health Enterprises IPO Issue Objectives

Repayment/ prepayment, in full or in part, of certain outstanding borrowings and accrued interest thereon availed by one of the Material Subsidiaries, Manipal Hospitals Private Limited - ₹5,378.0 Cr
Acquisition of minority stake in the stepdown Subsidiary, Sahyadri Hospitals Private Limited - ₹574.0 Cr
General corporate purposes

Manipal Health Enterprises IPO - Anchor Investors

Manipal Health Enterprises Limited finalised its anchor investor allocation on July 28, 2026, raising ₹4,167.10 crore from 133 institutional investors at an anchor price of ₹590 per share.

The anchor book comprises 7,06,28,768 equity shares allocated across domestic mutual funds, life insurance companies, NPS pension funds, and foreign portfolio investors. Domestic mutual funds received 40.01% of the anchor allocation through 21 fund houses across 55 schemes, including ICICI Prudential Mutual Fund, Kotak Mutual Fund, Aditya Birla Sun Life Mutual Fund, Mirae Asset, Motilal Oswal, UTI Mutual Fund, Whiteoak Capital, Axis Mutual Fund, HSBC Mutual Fund, Tata Mutual Fund, Bandhan, Invesco India, Franklin India, Sundaram, DSP, Baroda BNP Paribas, Edelweiss, JM Financial, Mahindra Manulife, Union, and PGIM India Mutual Fund. Notable foreign institutional participants include Nomura India Investment Fund Mother Fund at 3.83%, DSP Healthcare Fund at 2.63%, Abu Dhabi Investment Authority (two funds), Government Pension Fund Global, Polar Capital Healthcare Opportunities Fund, Public Sector Pension Investment Board, Carmignac Portfolio, Fidelity (multiple funds), Franklin Templeton (multiple funds), Prazim Trading and Investment Co., SBI Life Insurance, HDFC Life Insurance, ICICI Prudential Life Insurance, and LSOI SPV funds.

Manipal Health Enterprises IPO - Peers Comparison

P/B Ratio P/E Ratio RoNW Revenue(in Cr.)
Manipal Health N/A N/A N/A 10335
Apollo Hospitals N/A 66.15 N/A 25228
Fortis Health N/A 70.22 N/A 9127
Max Healthcare N/A 74.55 N/A 10065

Manipal Health Enterprises IPO - Strengths and Risks

Manipal Health Enterprises IPO strengths and risks highlight key business factors, financial position, and market sentiment that may impact investor interest.

Strengths

Experienced Management: The company is managed by an experienced management backed by strong institutional shareholders, thereby assuring stability, growth, and operational continuity.
Leader in Major Metropolitan Markets: Only private hospital chain that is a leader in the metropolitan cities of Bengaluru, Kolkata, and Pune with a balanced market network in metros and non-metros cities.
Advanced Healthcare Infrastructure: Operates modern hospitals with advanced medical technology, delivering high-quality tertiary and quaternary care through a decentralized and efficient operating model.

Risks

Dependence on Inpatient Revenues: The company is highly dependent on inpatient revenues. Reduction in patients' admissions or low occupancy rates can impact revenue and profitability.
Risk associated with Healthcare and Regulatory Compliance: Company could be subject to legal, operational, regulatory actions, equipment failure or hospital disruption, etc. that can negatively impact its reputation and financial performance.
Healthcare & Regulatory Risk: The company may face legal claims, regulatory actions, operational risks, equipment failures, or hospital disruptions, which could affect its reputation and financial performance.

Contact Information

Contact Details

Manipal Health Enterprises

+91 80 4936 0300

legalcs@manipalhospitals.com

https://www.manipalhospitals.com

The Annexe, #98/2, Rustom Bagh, HAL Airport Road, Bengaluru, Karnataka - 560017.

Registrar Contact Details

Kfin Technologies Limited

04067162222, 04079611000

manipal.ipo@kfintech.com

https://ipostatus.kfintech.com/

Frequently Asked Questions

Click any question to reveal the answer

Manipal Health Enterprises IPO is a book-built IPO worth ₹9275.21 crore. The price band is ₹560–₹590 per share. The IPO opens on Jul 29, 2026 and closes on Jul 31, 2026. It will be listed on BSE and NSE. Kfin Technologies Limited is the registrar.

The price band of Manipal Health Enterprises IPO is ₹560 to ₹590 per share.

The lot size of Manipal Health Enterprises IPO is 25 shares.

The minimum investment for Manipal Health Enterprises IPO is approximately ₹14,750 based on the upper price band .

Manipal Health Enterprises IPO opens on Jul 29, 2026 and closes on Jul 31, 2026.

The allotment date of Manipal Health Enterprises IPO is Aug 3, 2026.

Manipal Health Enterprises IPO is expected to be listed on Aug 5, 2026, on BSE and NSE .

No GMP quote could be verified as recorded before Manipal Health Enterprises IPO listed. A grey-market observation of ₹3 per share was recorded on 5 Aug 2026, 7:15 AM IST, but without a verified listing timestamp it is not treated as the final pre-listing GMP. The shares listed at ₹652. GMP is unofficial and does not forecast or guarantee the actual listing price.

Manipal Health Enterprises IPO listed on Aug 5, 2026. It was issued at ₹652.0(NSE) and is currently around ₹715.30 as on 21-Aug-2026 3:30 PM, which is approximately 21.2% versus issue price. The 52-week high is ₹757.70.

Based on listing and post-listing performance, Manipal Health Enterprises IPO delivered around 21.2% over issue price. Whether it was worth applying depends on your risk profile, allocation, and holding horizon.

To buy Manipal Health Enterprises IPO shares after listing, log in to your broker app (such as Zerodha, Angel One, Groww, Upstox, ICICI Direct), search the stock symbol, place a delivery/CNC order, and confirm quantity and price.

Manipal Health Enterprises IPO valuation snapshot: P/E 84.65, EPS ₹6.97/-, P/B 8.13, RoNW 10.57%, and market cap ₹77,605.68 Cr.

To apply for Manipal Health Enterprises IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.

You can check the live subscription status of Manipal Health Enterprises IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.

Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.

If you pre-apply for Manipal Health Enterprises IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.

You can check Manipal Health Enterprises IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Manipal Health Enterprises IPO allotment status on IPO Ji for quick and easy access.